Cannabis - Aspectos regulatorios

Situación en diversos países

Países Bajos

Fuente: PubMed [Internet]. Bethesda (MD): US National Library of Medicine National Institutes of Health; [consulta 25 mayo 2022]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/

Detalles de búsqueda: (("cannabis"[MeSH Terms] OR "cannabis"[All Fields] OR "cannabi"[All Fields] OR "cannabis s"[All Fields]) AND ("legislation"[Publication Type] OR "legislation as topic"[MeSH Terms] OR "legislation"[All Fields]) AND ("netherlands"[MeSH Terms] OR "netherlands"[All Fields] OR "netherland"[All Fields])) AND (y_5[Filter])

 

2021

• Ramaekers JG, Mason NL, Kloft L, Theunissen EL. Reply to: Managing the high: developing legislation and detection methods for cannabis impairment. Nat Rev Neurosci. septiembre de 2021;22(9):585.
• Hordowicz M, Klimkiewicz A, Jarosz J, Wysocka M, Jastrzębska M. Knowledge, attitudes, and prescribing patterns of cannabis and cannabinoid-containing medicines among European healthcare workers: a systematic literature review. Drug Alcohol Depend. 1 de abril de 2021;221:108652.
• Cousijn J. Legal cannabis-what’s in it? Addiction. febrero de 2021;116(2):231-2.
• López-Pelayo H, Matrai S, Balcells-Olivero M, Campeny E, Braddick F, Bossong MG, et al. Supporting Future Cannabis Policy - Developing a Standard Joint Unit: A Brief Back-Casting Exercise. Front Psychiatry. 2021;12:675033.

2019

• Fix BV, Smith D, O’Connor R, Heckman BW, Willemsen MC, Cummings M, et al. Cannabis use among a nationally representative cross-sectional sample of smokers and non-smokers in the Netherlands: results from the 2015 ITC Netherlands Gold Magic Survey. BMJ Open. 3 de marzo de 2019;9(3):E024497.

2018

• Freeman TP, van der Pol P, Kuijpers W, Wisselink J, Das RK, Rigter S, et al. Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands. Psychol Med. octubre de 2018;48(14):2346-52.
• de Hoop B, Heerdink ER, Hazekamp A. Medicinal Cannabis on Prescription in The Netherlands: Statistics for 2003-2016. Cannabis Cannabinoid Res. 2018;3(1):54-5.

2016

• van Ooyen-Houben MMJ, Bieleman B, Korf DJ. Tightening the Dutch coffee shop policy: Evaluation of the private club and the residence criterion. Int J Drug Policy. 2016;31:113-20.
• Van Laar M, Van Der Pol P, Niesink R. Limitations to the Dutch cannabis toleration policy: Assumptions underlying the reclassification of cannabis above 15% THC. Int J Drug Policy. 2016;34:58-64.

2015

• Belackova V, Maalsté N, Zabransky T, Grund JP. «Should I Buy or Should I Grow?» How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic. Int J Drug Policy. marzo de 2015;26(3):296-310.